The cross-linking Mass Spectrometry (XL-MS) technique has enormous potential for studying the interactions between proteins, and it can provide detailed structural information about the interaction interfaces in large protein complexes. Such information has been difficult to obtain by conventional structural methods. One of the primary impediments to the wider use of the XL-MS technique is the extreme challenge in sequencing cross-linked peptides because of their complex fragmentation patterns in MS. A recent innovation is the development of MScleavable cross-linkers, which allows direct sequencing of component peptides for facile identification. Sulfoxides are an intriguing class of thermally-cleavable compounds that have been shown to fragment selectively during low-energy collisional induced dissociation (CID) analysis. One effective way to address the challenge of interpreting cross-linked sample data is to strategically design the linker to simplify MS sequencing of cross-linked peptides. Our group has demonstrated such a simplification through the design of CID-cleavable protein cross-linkers as outlined in Figure 1 . Other groups have also reported CID-cleavable cross-linkers. 4,5 DSSO (1) contains a sulfoxide group that cleaves in the MS instrument at lower collision energy than the peptide backbone. 6, 7 This selective fragmentation separates the two linked peptide chains, allowing simplified sequencing in MS 3 using conventional database searching tools. 3, 7 In combination with new bioinformatics tools, DSSO has been proven as a very effective protein crosslinker for elucidating structures of protein complexes because of its size, structural simplicity, and robust cleavable bonds. 3, 7 In addition, two new derivatives of DSSO have recently been developed for cross-linking studies, and their successful applications in probing protein-protein interactions further demonstrate the robustness of sulfoxide-containing CID-cleavable reagents.
The fragmentation pattern of DSSO interlinked peptides is more complex than desired. 9, 10 Although the DSSO molecule itself is symmetric, the fragmentation event is not, and this asymmetry leads each peptide chain in the cross-linked structure to produce two different daughter peaks in the MS 2 . A representative four-peak MS 2 pattern of a DSSO cross-linked peptide (α-β)
after CID-cleavage is illustrated in Figure 1 . Each peptide (α and β) produces two MS 2 peaks:
an alkene fragment and a sulfenic acid modified fragment. 7 Although the four-peak pattern is effective, it does require MS 3 sequencing of at least three of the four MS 2 fragments to ensure unambiguous identification of an inter-linked peptide in our current workflow. This increases MS n analysis time and leads to a fewer peptides being sequenced in a given experiment. In addition, the higher the number of MS 2 fragment ions, the lower the sensitivity observed for MS 3 sequencing. These limitations that are common to all published CID-cleavable linkers create a need for new linker designs. 4, 5 An appropriate new linker design would lead to one peak per peptide in MS 2 , facilitating targeted peak selection during MS 3 analysis, improving sensitivity, and decreasing cycle time. Our group envisioned a new derivative of DSSO that would result in equivalent mass modifications on all peptide fragments in MS 2 , thereby decreasing the number of peaks per crosslinked peptide in MS 2 and increasing the signal-to-noise ratio for these peaks. The Ranish group previously reported the CID-cleavable BDRG cross-linker 11 to address this problem. It is structurally complex, and fragments under CID to produce two peaks (one for each peptide component) that are one Dalton apart, thus allowing the observation of a pseudo two-fragment MS 2 pattern in a low-resolution instrument. This predictable pattern makes it easier to process MS 2 peaks, but it does not solve the complexity problem in MS 2 and can compromise the peptide identification accuracy. Therefore, it is desirable to develop a true equal-mass linker that would generate identical (isobaric) fragments in the MS 2 , and lead to only two predominant peaks in the MS 2 . Such an identical mass linker (IML) was the goal of our investigation. Herein we report the design and evaluation of new CID-cleavable identical mass cross-linkers based on the sulfoxide functional group to facilitate MS 2 and MS 3 sequencing.
Results and Discussion

Design and Synthesis of a double-fragmentation cross-linker
Two approaches to solving the problem of four-peak MS 2 were explored: one double fragmentation event, where two identical fragments would split from a central core, and one single fragmentation event, where two structurally different (yet isobaric), fragments would result. Our efforts began with the double fragmentation approach. It was hypothesized that a symmetrical linker with two cleavable sites would allow for identical mass modifications on both peptides in MS 2 . To this end, aryl disulfoxide 2 was designed with the goal of inducing two simultaneous fragmentation events during MS 2 , resulting in peptides with identical alkene modifications (Figure 2) . 12 If the desired fragmentation occurred, then MS 2 would have two peaks, corresponding to the two formerly interlinked peptides (α and β represent different peptides in Figure 2 ). Unfortunately, when peptides interlinked by aryl disulfoxide 2 were exposed to varying levels of CID energy in a Thermo Scientific LTQ Orbitrap XL mass spectrometer, only one of the two sulfoxide groups fragmented per CID event, resulting in a four-peak pattern similar to DSSO ( Figure 2 ).
The MS 3 of the sulfenic acid piece showed further fragmentation to the alkene, but did not cleave the peptide backbone. Increasing the energy of the fragmentation event did not significantly alter the outcome. Although the result is consistent with the physics of the CID step, we were surprised that the selectivity for single bond cleavage was high enough to render the symmetric design of disulfoxide 2 ineffective. The failure of the double fragmentation strategy stimulated a new design principle for identical mass linkers. While the desired double fragmentation of cross-linker 2 did not occur, it was observed that the fragmentation occurred selectively on the aliphatic side of the sulfoxide group.
This simple feature for controlling the direction of fragmentation of the sulfoxide was incorporated into the design of the new IML (3). The design concept is outlined in Figure 3 . Unlike prior cross-linkers, the new IML designs depend upon an asymmetric cross-linker and a selective sulfoxide cleavage. Cross-linking α-and β-peptides leads to two different structures, 4 and 4'. They should have similar mobility in the LC and are likely to elute together. They have the same elemental composition, and will result in MS 1 peaks of the same mass. The selective cleavage in the CID step will produce an α-peptide alkene 4α α α α and an α-peptide sulfenic acid 4'α α α α. Similarly, the β-peptide will be represented by a sulfenic acid 4β β β β and an alkene 4'β β β β. If the two sides of the cross-linker are carefully balanced, the sulfenic acid and alkene will have identical formulas and thus converge in MS
2
. Funneling both structures into MS 3 will result in a superimposable fragmentation pattern that could be directly sequenced. At each step along the way the molecular structures will be more complex than for DSSO, but the resulting MS spectra will be simpler because the components are isobaric. Initial investigations taught us that the thermal stability of the sulfoxide group could not be taken for granted. An effective sulfoxide bond must survive storage and crosslinking, only cleaving during the low energy CID step in the LCMS. To address this concern, control compounds 5 and 6 were prepared to determine the stability of relevant sulfoxide structures ( Figure 4 ). Both compounds 5 and 6 contain a secondary aromatic sulfoxide, but in one case it is benzylic and in the other case it is aliphatic. The two thioether model systems were prepared, oxidized with one equivalent of m-CPBA, and the resulting sulfoxides were monitored by 1 H NMR spectroscopy.
Alkyl substituted compound 5 showed a small amount of elimination over the course of a week.
However, aryl substituted compound 6 completely eliminated over the course of 24 hours. The latter outcome is surprising, and we note that stable secondary benzylic sulfoxides are known in the literature, but the addition of the ester group appears to accelerate the elimination reaction. 13 This data demonstrated that benzylic sulfoxides should be avoided in the IML designs, but that aliphatic sulfoxides are promising. Over the course of this project several proposed IML structures were designed, synthesized, and evaluated. The three IMLs structures are shown in Figure 5 as compounds 7, 8, and 9. In each design, a sulfur atom was incorporated as a stable thiophene moiety, to balance the sulfenic acid, and a methylene group was added to avoid labile benzylic sulfoxides, vida supra. In order to understand the CID-induced fragmentation of these structures, model sulfoxides 10 and 11 were prepared. They were designed to produce the same two molecular fragments as IML 3 (9) , but each of these isobaric molecular fragments can be tracked in the MS separately. Sulfoxides 7-11 define the cross-linkers and model compounds that were evaluated in this investigation.
The common building block for these cross-linkers is thiophenol 15, the preparation of which is outlined in Scheme 1. The route closely follows literature precedent. 14 3-Hydroxycinnamic acid 12 was converted to the methyl ester with sulfuric acid in methanol before reduction to the dihydrocinnamate 13. The resulting phenol was combined with N,N,-dimethylcarbamoyl chloride in the presence of DABCO, followed by thermal rearrangement to the dimethyl thiocarbamate at 300 °C. Subsequent hydrolysis with KOH in methanol and tetrahydrofuran yielded the free thiol carboxylic acid 15 (Scheme 1). 15 The thiophene half (18) for IML 1 (7) was prepared by lithiation of 2-methoxythiophene 16 and alkylation with allyl bromide. The ester was introduced using a Grubbs cross-metathesis with methyl acrylate (Scheme 2). 16, 17 These sequences provided enough material for compound characterization and MS evaluation; as a result, the yields for individual steps were not optimized. Thiophene conjugate acceptor 18 was coupled to thiophenol 15 with triethylamine in methanol to form the diester. Subsequent hydrolysis with lithium hydroxide led to the desired diacid 19. Preformed NHS TFA was used to activate the diacid to form the di-NHS ester. 18, 19 This procedure led to fewer side products and higher yields than the traditional EDCI coupling.
Oxidation to sulfoxide 7 (IML 1) with m-CPBA proceeded uneventfully. 10 Subsequent crosslinking studies on IML 1 showed that the compound decomposed (through loss of water) to 21
prior to MS analysis (Scheme 2). This unexpected instability stimulated the design of the two new linkers IML 2 (8) and IML 3 (9), which feature α-branching in place of β-branching to avoid the undesired rearrangement.
Scheme 1. Synthesis of thiol building block 15
IML 2 (8) was comprised of the thiophenol fragments 15 and a thiophene fragment with a benzylic methoxy substituent (24) . The desired thiophene was rapidly synthesized by a BaylisHillman reaction of 2-thiophenecarboxaldehyde 22 and methyl acrylate. 20 Methylation of the resulting alcohol using silver oxide and methyl iodide 21 was followed by lithium hydroxide hydrolysis of the ester to deliver the carboxylic acid 24. Direct Michael addition of thiols to acrylic acids with catalytic TBAF3H 2 O has been reported. 22 We incorporated this step in the sequence to avoid the hydrolysis step on the methyl ester since the hydrolysis step led to large amounts of elimination side product in the synthesis of IML 1 (7) . This approach decreased the step count and circumvented thiophenol elimination, but resulted in modest yields. 
MS Evaluation of IML Agents
The cross-linking behavior of IML 1 (7) was examined using model protein cytochrome C.
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Analysis of cross-linked cytochrome C by SDS-PAGE revealed that IML1 exhibits comparable cross-linking efficiency to DSSO, but MS data showed no sulfoxide fragmentation during CID.
The unused cross-linker was recovered and analyzed by ESI+ MS, showing loss of water. gel in Figure 6 shows both IML linkers exhibit considerable cross-linking activity. In the cytochrome C case, they were both comparable to DSSO; in the lysozyme case it appears they may have induced higher order aggregate species. With proof of protein cross-linking, IML crosslinked samples were subjected to MS analysis. Figure   9 ). The MS 2 peak representing the 1 + ion of thiophenol-modified Ac-IR7 was successfully sequenced in MS 3 ( Figure 9 ). As expected the MS 2 peaks generated from IR7-10 and IR7-11
had identical m/z 1024.48, satisfying our expectations for the design of the IML 3. Ac-IEAEK A GR Figure 9 . MS 2 and MS 3 spectra of Ac-IR7 modified by sulfenic acid control compound 11
Testing of IML 3 began with peptide cross-linking of Ac-TR9 (Acetyl-TTSYKVTIR) and Ac-IR7
(Acetyl-IEAEKGR). As expected, an IML 3 interlink showed identical mass modifications in MS 2 , achieving proof of concept for the desired two-peak pattern in MS 2 ( Figure 10 ). As predicted, the MS 2 of Ac-IR7 is identical for IML 3 and for both control compounds 10 and 11 (Figures 8-10 ). C NMR spectra were recorded at ambient temperature at 500 MHz and 125
MHz, respectively, on a Bruker DRX500 NMR instrument. The layers were separated and the aqueous layer was extracted with diethyl ether (2x). Organics were combined, washed with brine, dried over Na 2 SO 4 , filtered and evaporated in vacuo.
General procedure 2: TBAF-Promoted Michael Additions
Acrylic acid (0.28 mmol), thiophenol (0.51 mmol), and THF (1 mL) were combined in a round bottom flask to which TBAF•3H 2 O (0.06 mmol) was added at rt. The flask was fitted with a coldwater condenser and the mixture was heated to 50° C for 16 h. The mixture was cooled to rt, evaporated in vacuo, diluted with EtOAc and washed with 1N HCl (2x). The organic layer was washed with brine, dried over Na 2 SO 4 , filtered, and evaporated in vacuo to yield the crude product. In some cases, this reaction was run neat.
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General procedure 3: NHS Ester Preparation
Crude diacid (0.08 mmol) was dissolved in dry dichloromethane (0.62 mL) in a flame dried round bottom flask under argon. NHS•TFA (0.41 mmol) was added before a slow addition of triethylamine (0.49 mmol) at 0° C. The mixture was left to warm slowly overnight while stirring under argon. After 16 h, the mixture was diluted with dichloromethane and washed with water (2x). The organic layer was dried with Na 2 SO 4 , filtered, and evaporated in vacuo.
General procedure 4: m-CPBA-Oxidation to Sulfoxide
Di-NHS ester (0.026 mmol) was dissolved in CDCl 3 (1 mL) and m-CPBA (77% w/w, 0.026 mmol) was added slowly while monitoring by LRMS ESI + and 1 H NMR. When this reaction was run on larger scale than 30 mg starting material, the solution was cooled in an ice bath prior to m-CPBA addition. Once the reaction was complete, the solution was diluted with dichloromethane (2 mL) and washed with 10% sodium bicarbonate solution (3 x 2 mL). The organic layer was dried over Na 2 SO 4 , filtered, and evaporated in vacuo to afford the product.
Experimental Procedures Methyl 3-(3-hydroxyphenyl)propanoate (13). Acetyl chloride (4.39 mL, 61.5 mmol), m-
hydroxycinnamic acid (12) (10.0 g, 60.9 mmol), and methanol (300 mL) were combined in a round bottom flask, fitted with a cold water condenser, and heated to 70 °C for 4.5 h. The reaction mixture was cooled to room temperature and the solvent was removed and flushed with CH 2 Cl 2 . The crude methyl ester was dissolved in ethanol (206 mL) and acetic acid (11.0 mL) before addition of Pd/C (5% by wt, 6.50 g, 3.05 mmol). The headspace was evacuated and a balloon of H 2 gas was attached to the flask. The reaction stirred for two days and there was no change in R f . The reaction mixture was filtered through Celite and solvent was removed in vacuo. The crude product was purified by flash column chromatography (30% EtOAc/hexanes) to yield desired methyl ester 13 (8.82 g, 80%). Spectra were identical to previously reported data. 
Methyl 3-(3-((dimethylcarbamothioyl)oxy)phenyl)propanoate (14
Methyl 3-(3-((dimethylcarbamoyl)thio)phenyl)propanoate (34). Starting protected alcohol
14 (0.2 g, 0.748 mmol) was placed in a crimp-top vial and sealed under argon. The neat oil was placed in a 310 °C sand bath. After 20 min, the reaction was complete by TLC and the vial was allowed to cool to rt. The crude product was purified by flash column chromatography (20% EtOAc/hexanes) to yield dark yellow oil product 34 (91 mg, 45% (16) (1.1 g, 1.0 mL, 9.9 mmol) was dissolved in dry diethyl ether (28 mL) in a flame dried round bottom flask. sec-Butyllithium (13.7 mL of [0.72] solution, 9.9 mmol) was added to the mixture dropwise at 0 °C. After 90 min, the reaction mixture was cooled to -78 °C allyl bromide (0.86 mL, 9.9 mmol) was added. The reaction was allowed to slowly warm and stir overnight. The reaction was cooled to 0 °C before addition of saturated ammonium chloride solution (14 mL). The layers were separated before the aqueous layer was extracted with diethyl ether (2x). The organic layers were combined, washed with brine, and dried over MgSO 4 before being filtered and evaporated. The crude product was purified by flash column chromatography (pentane) to yield the product as a green oil (0.70 g, 46% Methyl 2-(hydroxy(thiophen-2-yl)methyl)acrylate 23. Thiophene carboxaldehyde 22 (5 mL, 0.054 mmol) and methyl acrylate (6.24 mL, 0.070 mmol) were combined with DABCO (3.9 g, 0.035 mmol) in a round bottom flask and the mixture was sonicated for 24-48 h. The resulting mixture was loaded onto a silica gel column and the product was isolated by flash chromatography as yellow oil (7.14 g, 66%). Spectra were identical to previously reported data. The vial was evacuated and backfilled with argon before heating to 50 °C overnight. The solvent was removed in vacuo before the crude mixture was purified by flash column chromatography (60% EtOAc/hexanes) to yield desired product (0.047 g, 63% After one hour, the reaction mixture was cooled to -78 °C before slow addition of N-Ndimethylformamide (1.38 mL, 17.8 mmol). Once the addition was complete, the reaction mixture was left to warm slowly to rt and stir overnight. Crude product was purified by flash chromatography to yield 1.1 g (78%) of the desired product. Spectra were identical to previously reported data. The reaction flask was allowed to cool to rt before the solvent was removed in vacuo. Diethyl ether was added to redissolve the mixture and the organic solution was washed with 10% hydrochloric acid solution (3x), saturated sodium bicarbonate solution (3x), and brine (1x) before it was filtered and the solvent was removed in vacuo. The product 27 (6.20 g, 98%) was not purified. 24 The resulting crude product was dissolved in ethanol and cooled to 0° C. Sodium borohydride (0.429 g, 11.3 mmol) was added to the solution and gas evolved. After 45 min, the ice bath was removed and the solution was heated to 40° C in an oil bath. Reaction progress was monitored by TLC (20% EtOAc/hexanes). Once the reaction was complete, water was added before adding acetic acid to pH 4. Solids were filtered off and diethyl ether and water were added to the filtrate. The layers were separated, the organics washed with water and brine before drying with was added slowly to the mixture by addition funnel. After 150 min, the mixture was cooled to 0° C and diethyl ether was added to induce further crystallization. The solids were filtered off and rinsed with heptane. The isolated solids were dissolved in saturated bicarbonate solution and
2-Allyl-5-methoxythiophene (17). 2-Methoxythiophene
3-((3-(2-Carboxyethyl)phenyl)thio)-4-(5-methoxythiophen-2-yl)butanoic acid (19)
.5.9, 1H), 2.53 (app dd, J = 16.1, 8.2, 1H); 13 C NMR (125 MHz, CDCl 3 ) δ 178.9, 177.6, 165.4
Di-NHS
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Methyl 2-(methoxy(thiophen-2-yl)methyl)acrylate (36)
EtOAc was added. Concentrated HCl was added to pH 1 and the aqueous layer was extracted (3 x 75 mL). The organic layer was washed with brine, dried over Na 2 SO 4 , filtered, and evapo-rated in vacuo. The crude product was isolated as a white crystalline solid (5.63 g, 48%) . m.p. 3-(2-Carboxyethyl)phenyl)thio)-2-((5-methoxythiophen-2-yl) 
3-((
IML 3 (9)
. Sulfoxide 9 was prepared from di-NHS ester 39 (0.030 g, 0.052 mmol) using general procedure 4. The isolated product appeared as an orange oil (27 mg, 87%). The product was characterized as a 1:0.7 mixture of diastereomers, with a very small amount of starting sulfide that was not consumed in the reaction. 
Procedure for protein cross-linking and LCMS analysis
Cytochrome C and lysozyme were purchased from Sigma. Cross-linking of these proteins followed the same procedure as described previously. 
